mRNA-1273.712

ApprovedCompleted
0 views this week 0 watching
0
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Healthy Volunteers

Conditions

Healthy Volunteers

Trial Timeline

Oct 8, 2024 → Jan 20, 2025

About mRNA-1273.712

mRNA-1273.712 is a approved stage product being developed by Moderna for Healthy Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT06634797. Target conditions include Healthy Volunteers.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Volunteers were approved

Approved (20) Terminated (1) Active (0)

Clinical Trials (1)

NCT IDPhaseStatus
NCT06634797ApprovedCompleted

Competing Products

20 competing products in Healthy Volunteers

See all competitors
ProductCompanyStageHype Score
Use of Wearable Digital Sensors After mRNA Vaccination in AdultsModernaPreclinical
0
mRNA-0184ModernaPhase 1
0
mRNA-6231ModernaPhase 1
0
LetrozoleDr. Reddy's LaboratoriesPhase 1
26
IsotretinoinDr. Reddy's LaboratoriesPhase 1
26
FexofenadineDr. Reddy's LaboratoriesPhase 1
26
SertralineDr. Reddy's LaboratoriesPhase 1
26
Nizatidine + AxidDr. Reddy's LaboratoriesPhase 1
26
AnastrozoleDr. Reddy's LaboratoriesPhase 1
26
RisperidoneDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
Metformin + GlucophageDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
mRNA-0184ModernaPhase 1
0
Divalproex SodiumDr. Reddy's LaboratoriesPhase 1
26
SirolimusDr. Reddy's LaboratoriesPhase 1
26
GlimepirideDr. Reddy's LaboratoriesPhase 1
26
Ziprasidone HydrochlorideDr. Reddy's LaboratoriesPhase 1
26
Naproxen sodiumDr. Reddy's LaboratoriesPhase 1
26
LansoprazoleDr. Reddy's LaboratoriesPhase 1
26